Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Actilyse 20mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Actilyse 50mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fasturtec 1.5mg powder and solvent for solution for infusion vials (Sanofi Genzyme) 3 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fasturtec 7.5mg powder and solvent for solution for infusion vials (Sanofi Genzyme) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fludara 50mg powder for solution for injection vials (Schering Health Care Ltd) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BeneFIX 250unit powder and solvent for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BeneFIX 500unit powder and solvent for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BeneFIX 1,000unit powder and solvent for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
AlphaNine 500unit powder and solvent for solution for injection vials (Alpha Therapeutic UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cancidas 70mg powder for solution for infusion vials (Organon Pharma (UK) Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
GHRH Ferring 50microgram powder and solvent for solution for injection ampoules (Ferring Pharmaceuticals Ltd) 1 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Menogon 75unit powder and solvent for solution for injection ampoules (Ferring Pharmaceuticals Ltd) 10 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Menopur 75unit powder and solvent for solution for injection vials (Ferring Pharmaceuticals Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haemate P 1,000unit powder and solvent for solution for injection vials (Aventis Behring Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haemate P 500unit powder and solvent for solution for injection vials (Aventis Behring Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cerezyme 200unit powder for solution for injection vials (Genzyme Therapeutics) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cerezyme 400unit powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Copaxone 20mg powder and solvent for solution for injection vials (Teva UK Ltd) 28 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Streptomycin 1g powder for solution for injection vials (Celltech Pharmaceuticals Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 600microgram powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 800microgram powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 1.2mg powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 600mg powder for solution for injection vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 60,000unit powder and solvent for solution for injection pre-filled disposable devices (Roche Products Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 1mg powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 1.4mg powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 1.6mg powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 1.8mg powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 2mg powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Saizen 1.33mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Humatrope 1.3mg powder and solvent for solution for injection vials (Eli Lilly & Co Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Kefzol 1g powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gonal-f 37.5unit powder and solvent for solution for injection ampoules (Serono Laboratories (UK) Ltd) 1 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gonal-f 37.5unit powder and solvent for solution for injection ampoules (Serono Laboratories (UK) Ltd) 10 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Leucomax 150microgram powder and solvent for solution for injection vials (Schering-Plough Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pharmalgen Wasp Venom maintenance set 120microgram vaccine powder and solvent for solution for injection vials (ALK-Abello (UK)) 4 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Simulect 10mg powder and solvent for solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cyclophosphamide 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cyclophosphamide 500mg powder for solution for injection vials (Pfizer Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cyclophosphamide 500mg powder for solution for injection vials (Unichem Plc) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gonal-f 75unit powder and solvent for solution for injection vials (PI) (Waymade Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gonal-f 75unit powder and solvent for solution for injection vials (PI) (Waymade Ltd) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gonal-f 75unit powder and solvent for solution for injection vials (PI) (Waymade Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 10,000unit powder and solvent for solution for injection pre-filled disposable devices (Roche Products Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 10,000unit powder and solvent for solution for injection pre-filled disposable devices (Roche Products Ltd) 3 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 20,000unit powder and solvent for solution for injection pre-filled disposable devices (Roche Products Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 20,000unit powder and solvent for solution for injection pre-filled disposable devices (Roche Products Ltd) 3 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Avonex 30microgram powder and solvent for solution for injection vials (PI) (Dowelhurst Ltd) 4 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Desferrioxamine 500mg powder for solution for injection vials (Mayne Pharma Plc) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Desferrioxamine 2g powder for solution for injection vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gonal-f 150unit powder and solvent for solution for injection ampoules (PI) (Dowelhurst Ltd) 1 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gonal-f 75unit powder and solvent for solution for injection vials (PI) (Dowelhurst Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gonal-f 75unit powder and solvent for solution for injection vials (PI) (Dowelhurst Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Metrodin High Purity 75unit powder and solvent for solution for injection ampoules (PI) (Dowelhurst Ltd) 3 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Metrodin High Purity 75unit powder and solvent for solution for injection ampoules (PI) (Dowelhurst Ltd) 1 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-amoxiclav 500mg/100mg powder for solution for injection vials (C P Pharmaceuticals Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-amoxiclav 1000mg/200mg powder for solution for injection vials (C P Pharmaceuticals Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Zyprexa 10mg powder for solution for injection vials (Parapharm Development Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Thiopental 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 25 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Endoxana 1g powder for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cyclophosphamide 1g powder for solution for injection vials (Pfizer Ltd) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Endoxana 200mg powder for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mitoxana 2g powder for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mitoxana 1g powder for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Thiotepa 15mg powder for solution for injection vials (Cyanamid UK) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mitomycin-C Kyowa 40mg powder for intravesical solution vials (Kyowa Kirin Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mitomycin-C Kyowa 10mg powder for solution for injection vials (Kyowa Hakko) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mitomycin-C Kyowa 20mg powder for solution for injection vials (Kyowa Hakko) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mitomycin-C Kyowa 2mg powder for solution for injection vials (Kyowa Hakko) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tomudex 2mg powder for solution for injection vials (AstraZeneca) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Eloxatin 50mg powder for solution for injection vials (Sanofi-Synthelabo Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Eloxatin 100mg powder for solution for injection vials (Sanofi-Synthelabo Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Photofrin 15mg powder for solution for injection vials (Sinclair Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Photofrin 75mg powder for solution for injection vials (Sinclair Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ultiva 1mg powder for solution for injection vials (Medeus Pharma) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ultiva 2mg powder for solution for injection vials (Medeus Pharma) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ultiva 5mg powder for solution for injection vials (Medeus Pharma) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hycamtin 1mg powder for solution for injection vials (SmithKline Beecham Pharmaceuticals) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nexium I.V 40mg powder for solution for injection vials (Grunenthal Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 1g powder for solution for injection vials (Medac GMBH) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 100mg powder for injection vials (Medac GMBH) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 500mg powder for solution for injection vials (Medac GMBH) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Solivito N powder for concentrate for solution for infusion vials (Fresenius Kabi Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Eldisine 5mg powder for solution for injection vials (Clonmel Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Velcade 3.5mg powder for solution for injection vials (Ortho Biotech) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somavert 10mg powder and solvent for solution for injection vials (Pfizer Ltd) 30 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somavert 15mg powder and solvent for solution for injection vials (Pfizer Ltd) 30 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somavert 20mg powder and solvent for solution for injection vials (Pfizer Ltd) 30 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
ReFacto 2,000unit powder and solvent for solution for injection vials (Wyeth Laboratories) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
WinRho SDF 1,500units powder and solvent for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
WinRho SDF 5,000units powder and solvent for solution for injection vials (Baxter Healthcare Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Refludan 50mg powder for solution for injection vials (Pharmion Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Kefzol 500mg powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Advate 250unit powder and solvent for solution for injection vials (Shire Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Advate 500unit powder and solvent for solution for injection vials (Shire Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Advate 1,000unit powder and solvent for solution for injection vials (Takeda UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Advate 1,500unit powder and solvent for solution for infusion vials (Takeda UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somavert 20mg powder and solvent for solution for injection vials (Pfizer Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|